The approval was based on data from a Phase II trial, two retrospective chart review studies and an expanded access programme ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

In today's fast-paced digital landscape, brands face an unprecedented challenge: creating high-quality, consistent content at ...

UCB has scored an FDA approval for ultra-rare disease treatment Kygevvi, continuing the positive momentum for the Belgian ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

Bigger animals such as whales and elephants, should have a higher risk of succumbing to cancer as they have more cells dividing over a longer period, leaving more room for mutations.

Everyone knows that the fall brings flu season, replete with aches, pains and a new version of the vaccine. But why is cold ...

A groundbreaking FDA approval offers the first-ever treatment for ultra-rare Thymidine Kinase 2 Deficiency (TK2d). KYGEVVI, a ...

The legendary QB cloned his dog, Lua, who passed away in 2023. Here’s more on the process, specifics and the legality of the ...

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, today announced that KYGEVVI® has been granted approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults and ...

Memory may not appear on a balance sheet, but it is the most undervalued asset in business—the silent engine of trust, creativity, and resilience. In the end, innovation fades, but memory endures.